PYXS Pyxis Oncology, Inc.
Fundamentals / CIK 0001782223 / USDPyxis Oncology, Inc. reported $13.86M in revenue and a net loss of $86.71M for the fiscal year ended December 31, 2025 (down 14.2% year over year), with a 82.8% gross margin and a -643.4% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PYXS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$13.86M -14.2% YoY
-
Operating Income FY 2025-$89.17M -643.4% margin
-
Net Income FY 2025-$86.71M -625.7% net margin
-
Diluted EPS FY 2025-$1.04 Split-adjusted
-
Free Cash Flow FY 2025-$63.51M -458.3% FCF margin
-
Cash & ST Investments Sep 30, 2026$55.57M Total debt: $17.40M
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $13.86M | $16.15M | -- | -- | -- | -- |
| Cost of Revenue | $2.39M | $475K | -- | -- | -- | -- |
| Gross Profit | $11.47M | $15.67M | -- | -- | -- | -- |
| Research & Development | $73.70M | $58.75M | $49.59M | $86.13M | $51.05M | $9.05M |
| Total Operating Expenses | -- | -- | $82.20M | $123.5M | $69.72M | $12.89M |
| Operating Income | -$84.42M | -$89.46M | -$82.20M | -$123.5M | -$69.72M | -$12.89M |
| EBITDA | -$79.91M | -$86.48M | -$80.27M | -$122.8M | -$69.07M | -$12.43M |
| Interest Income | $650K | $930K | $1.84M | $2.76M | $23K | $66K |
| Income Before Tax | -$78.23M | -$79.50M | -$73.79M | -- | -- | -- |
| Income Tax Expense | $1.39M | -$2.16M | -- | -- | -- | -- |
| Net Income | -$79.62M | -$77.33M | -$73.79M | -$120.7M | -$75.97M | -$12.83M |
| Basic EPS | -$1.28 | -$1.32 | -$1.85 | -$3.65 | -$8.95 | -$12.45 |
| Diluted EPS | -$1.28 | -$1.32 | -$1.85 | -$3.65 | -$8.95 | -$12.45 |
| Basic Shares Outstanding | 62.1M | 58.4M | 39.9M | 33.0M | 8.5M | 1.0M |
| Diluted Shares Outstanding | 62.1M | 58.4M | 39.9M | 33.0M | 8.5M | 1.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | $2.82M | -- | $0 |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $0 |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | $0 |
| Research & Development | $16.56M | $16.06M | $19.98M | $21.71M | $17.81M | $17.13M | $17.04M | $14.02M |
| Total Operating Expenses | $20.52M | $25.99M | $24.36M | -- | $23.46M | $22.57M | $22.91M | -- |
| Operating Income | -$20.52M | -$25.99M | -$24.36M | -$18.30M | -$23.46M | -$19.75M | -$22.91M | -$40.07M |
| EBITDA | -$20.22M | -$25.69M | -$23.90M | -$15.40M | -$22.93M | -$19.21M | -$22.36M | -$39.52M |
| Interest Income | $201K | $61K | $218K | $225K | $242K | $99K | $84K | $87K |
| Income Before Tax | -$19.98M | -$25.35M | -- | -- | -$22.00M | -$18.07M | -- | -- |
| Income Tax Expense | $0 | $0 | -- | -- | $0 | $283K | -- | -- |
| Net Income | -$19.98M | -$25.35M | -$23.27M | -$18.11M | -$22.00M | -$18.35M | -$21.16M | -$35.57M |
| Basic EPS | -$0.24 | -$0.40 | -$0.37 | -- | -$0.35 | -$0.30 | -$0.35 | -- |
| Diluted EPS | -$0.24 | -$0.40 | -$0.37 | -- | -$0.35 | -$0.30 | -$0.35 | -- |
| Basic Shares Outstanding | 83.5M | 64.0M | 63.5M | -- | 62.6M | 61.9M | 61.0M | -- |
| Diluted Shares Outstanding | 83.5M | 64.0M | 63.5M | -- | 62.6M | 61.9M | 61.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $15.42M | $19.47M | $9.66M | $179.3M | $274.7M | $8.08M |
| Short-Term Investments | $51.44M | $107.5M | $109.6M | -- | -- | -- |
| Cash & Short-Term Investments | $66.90M | $126.9M | $119.3M | $179.3M | $274.7M | $8.08M |
| Other Current Assets | $626K | $434K | $326K | $381K | $84K | $15K |
| Total Current Assets | $72.11M | $132.4M | $124.6M | $186.6M | $278.7M | $8.10M |
| Property, Plant & Equipment, Net | $8.00M | $9.90M | $11.87M | $11.16M | $1.01M | $1.10M |
| Intangible Assets | $0 | $2.60M | $24.31M | -- | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | $109K | $109K |
| Total Non-Current Assets | $19.41M | $24.74M | $49.12M | $24.77M | $1.35M | $2.05M |
| Total Assets | $91.52M | $157.2M | $173.7M | $211.4M | $280.0M | $10.15M |
| Accounts Payable | $10.88M | $4.86M | $3.90M | $7.10M | $11.95M | $1.08M |
| Deferred Revenue (Current) | -- | -- | $7.66M | -- | -- | -- |
| Total Current Liabilities | $21.13M | $17.68M | $25.76M | $31.63M | $18.71M | $3.69M |
| Total Non-Current Liabilities | $16.98M | $18.75M | $22.26M | $18.92M | $0 | $165K |
| Total Liabilities | $38.11M | $36.43M | $48.02M | $50.55M | $18.71M | $3.85M |
| Total Debt (incl. Leases) | $18.67M | $20.20M | $21.33M | $18.92M | $165K | $780K |
| Common Stock | $63K | $60K | $45K | $34K | $32K | $1.0K |
| Retained Earnings | -$443.2M | -$363.6M | -$286.2M | -$212.4M | -$91.72M | -$15.74M |
| Accumulated Other Comp. Income | $53K | $170K | $63K | -- | -- | -- |
| Total Stockholders' Equity | $53.41M | $120.8M | $125.7M | $160.8M | $261.3M | -$15.64M |
| Total Equity | $53.41M | $120.8M | $125.7M | $160.8M | $261.3M | -$15.64M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.86M | $18.86M | $5.77M | $15.42M | $8.92M | $10.73M | $12.76M | $19.47M |
| Short-Term Investments | $51.72M | $14.14M | $35.25M | $51.44M | $67.34M | $78.21M | $92.67M | $107.5M |
| Cash & Short-Term Investments | $55.60M | $33.00M | $41.00M | $66.90M | $76.30M | $88.90M | $105.4M | $126.9M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | $3.00M | -- | -- |
| Other Current Assets | -- | -- | -- | $626K | -- | -- | -- | $434K |
| Total Current Assets | $59.13M | $36.73M | $45.57M | $72.11M | $83.07M | $99.96M | $111.9M | $132.4M |
| Property, Plant & Equipment, Net | $6.94M | $7.24M | $7.54M | $8.00M | $8.46M | $8.92M | $9.40M | $9.90M |
| Intangible Assets | -- | -- | -- | $0 | $2.43M | $2.49M | $2.54M | $2.60M |
| Total Non-Current Assets | $17.64M | $18.19M | $18.73M | $19.41M | $22.53M | $23.26M | $24.00M | $24.74M |
| Total Assets | $76.77M | $54.92M | $64.30M | $91.52M | $105.6M | $123.2M | $135.9M | $157.2M |
| Accounts Payable | $8.12M | $3.27M | $4.99M | $10.88M | $9.76M | $9.41M | $2.85M | $4.86M |
| Total Current Liabilities | $19.94M | $27.47M | $16.53M | $21.13M | $19.38M | $17.68M | $14.43M | $17.68M |
| Total Non-Current Liabilities | $15.51M | $16.01M | $16.50M | $16.98M | $17.44M | $17.89M | $18.33M | $18.75M |
| Total Liabilities | $35.45M | $43.48M | $33.03M | $38.11M | $36.83M | $35.57M | $32.76M | $36.43M |
| Total Debt (incl. Leases) | $17.40M | $17.83M | $18.26M | $18.67M | $19.07M | $19.46M | $19.84M | $20.20M |
| Common Stock | $83K | $63K | $63K | $63K | $62K | $62K | $62K | $60K |
| Retained Earnings | -$511.8M | -$491.8M | -$466.4M | -$443.2M | -$425.1M | -$403.1M | -$384.7M | -$363.6M |
| Accumulated Other Comp. Income | -$56K | -$4.0K | $0 | $53K | $69K | -$5.0K | $49K | $170K |
| Total Stockholders' Equity | $41.32M | $11.44M | $31.27M | $53.41M | $68.78M | $87.64M | $103.1M | $120.8M |
| Total Equity | $41.32M | $11.44M | $31.27M | $53.41M | $68.78M | $87.64M | $103.1M | $120.8M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$79.62M | -$77.33M | -$73.79M | -$120.7M | -$75.97M | -$12.83M |
| Depreciation & Amortization | $4.51M | $2.98M | $1.93M | $709K | $647K | $469K |
| Stock-Based Compensation | $11.80M | $12.95M | $16.95M | $15.76M | $6.44M | $44K |
| Change in Payables | $6.03M | $1.20M | -$3.51M | -$8.33M | $4.64M | $558K |
| Operating Cash Flow | -$63.50M | -$57.67M | -$70.71M | -$89.33M | -$35.33M | -$10.08M |
| Capital Expenditure | -$9.0K | -$237K | -$6.73M | -$6.40M | -$540K | -$1.48M |
| Free Cash Flow | -$63.51M | -$57.91M | -$77.44M | -$95.73M | -$35.87M | -$11.57M |
| Purchases of Investments | -$107.0M | -$160.1M | -$196.8M | -- | -- | -- |
| Investing Cash Flow | $58.86M | $8.15M | -$104.8M | -$6.40M | -$590K | -$1.48M |
| Common Stock Issued | -- | -- | -- | -- | -- | $3.0K |
| Financing Cash Flow | $594K | $59.33M | $5.93M | $183K | $304.0M | $35K |
| Net Change in Cash | -$4.05M | $9.81M | -$169.6M | -$95.55M | $268.1M | -$11.53M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$19.98M | -$25.35M | -$23.27M | -$18.11M | -$22.00M | -$18.35M | -$21.16M | -$35.57M |
| Depreciation & Amortization | $299K | $301K | $459K | $2.90M | $527K | $535K | $552K | $550K |
| Stock-Based Compensation | $1.33M | $5.53M | $1.21M | $2.08M | $3.07M | $3.02M | $3.63M | $2.77M |
| Change in Payables | $4.86M | -$1.72M | -$5.90M | $1.13M | $344K | $6.57M | -$2.01M | -$10K |
| Operating Cash Flow | -$16.29M | -$18.21M | -$26.00M | -$10.43M | -$13.28M | -$17.26M | -$22.54M | -$19.29M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -- | -$19.29M |
| Purchases of Investments | -$49.37M | -$3.00M | -$10.99M | $0 | -$14.56M | -$41.10M | -$51.35M | -$4.37M |
| Investing Cash Flow | -$37.29M | $21.30M | $16.37M | $16.26M | $11.47M | $15.30M | $15.82M | $26.66M |
| Financing Cash Flow | $38.59M | $9.99M | -$25K | $669K | -$8.0K | -$67K | $0 | $50K |
| Net Change in Cash | -$15.00M | $13.09M | -$9.66M | $6.50M | -$1.81M | -$2.03M | -$6.71M | $7.42M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Gross Margin | 82.8% | 97.1% | -- | -- | -- | -- |
| Operating Margin | -609.2% | -554.1% | -- | -- | -- | -- |
| Net Profit Margin | -574.5% | -478.9% | -- | -- | -- | -- |
| Return on Equity (ROE) | -149.1% | -64.0% | -58.7% | -75.1% | -29.1% | -- |
| Return on Assets (ROA) | -87.0% | -49.2% | -42.5% | -57.1% | -27.1% | -126.4% |
| Current Ratio | 3.41x | 7.49x | 4.84x | 5.90x | 14.90x | 2.20x |
| Quick Ratio | 3.17x | 7.18x | 4.63x | 5.67x | 14.69x | 2.19x |
| Debt to Equity | 0.35x | 0.17x | 0.17x | 0.12x | 0.00x | -- |
| Revenue Growth (YoY) | -14.2% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -26.8% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | -- | 97.1% |
| Operating Margin | -- | -- | -- | -- | -- | -- | -- | -554.1% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -- | -478.9% |
| Return on Equity (ROE) | -209.8% | -775.6% | -261.4% | -149.1% | -141.2% | -109.9% | -92.4% | -64.0% |
| Return on Assets (ROA) | -112.9% | -161.6% | -127.1% | -87.0% | -91.9% | -78.1% | -70.1% | -49.2% |
| Current Ratio | 2.96x | 1.34x | 2.76x | 3.41x | 4.29x | 5.65x | 7.75x | 7.49x |
| Quick Ratio | 2.79x | 1.20x | 2.48x | 3.17x | 3.94x | 5.20x | 7.30x | 7.18x |
| Debt to Equity | 0.42x | 1.56x | 0.58x | 0.35x | 0.28x | 0.22x | 0.19x | 0.17x |